HOME > INVESTOR > ARCHIVES > PRESS RELEASE
December 2013
Lupin launches Generic Trizivir® Tablets
Date: December 18 Size: 148Kb
Lupin launches Generic Cymbalta® Delayed-Release Capsules 20 mg, 30 mg and 60 mg strengths in the US
Date: December 12 Size: 150Kb
Lupin Receives FDA Approval for Generic Trizivir® Tablets
Date: December 10 Size: 146Kb
Lupin launches Generic Trilipix® Delayed-Release Capsules 45 mg & 135 mg in the US
Date: December 06 Size: 150Kb

 

November 2013
Lupin launches Generic Aciphex® Delayed-Release Tablets, 20 mg in the US
Date: November 11 Size: 149Kb

 

October 2013
Consistent Growth, Robust Profits Quarter II Results, FY 2013-14 Net Sales up 18%; EBITDA up 42%; Net profit up 40%
Date: October 20 Size: 310Kb
Lupin Receives FDA Approval for its New Drug Application for Antara® Capsules
Date: October 22 Size: 151Kb
Lupin Receives International Sustainability Rating Standard (ISRS) Certification First Pharmaceutical Company globally to adopt ISRS, 8th Edition standard
Date: October 18 Size: 125Kb
Lupin launches Generic ZYMAXID™ Ophthalmic solution in the US
Date: October 3 Size: 150Kb

 

September 2013
Lupin receives FDA approval for its Oral Contraceptive VyfemlaTM Tablets Generic of Ovcon® 35 Tablets
Date: September 27 Size: 152Kb
Lupin Expands US Pediatric Brands Portfolio Inks Strategic Agreement to Promote Locoid® Lotion to US Pediatricians
Date: September 23 Size: 147Kb
Lupin Receives FDA Approval for Generic Ambien CR® Extended-release Tablets
Date: September 16 Size: 154Kb

 

August 2013
Lupin Receives FDA Approval for Generic Rifadin® Capsules
Date: August 23 Size: 175Kb
Strong Margins, Robust Profitability Quarter I Results, FY 2013-14 EBITDA up 44%, Net profit up 43%
Date: August 7Size: 262Kb
Lupin Expands Branded Play Announces Acquisition of Exclusive US Rights to Alinia® for Oral Suspension
Date: August 7Size: 147Kb
Lupin receives FDA Approval for Generic Ranexa® Extended-release Tablets
Date: August 1Size: 172Kb

 

July 2013
Lupin Receives Tentative FDA Approvals for Generic Nuvigil® Tablets and Generic Oracea® Capsules
Date: July 31Size: 174Kb
MSD and Lupin announce Strategic Partnership to Co-market MSD's 23-valent Pneumococcal polysaccharide vaccine (PPV) for Indian market
Date: July 18Size: 51.7Kb

 

May 2013
Record Sales and Profits
Date: April 26Size: 230Kb
Lupin announces Executive Board Leadership Changes
Date: April 17Size: 128Kb

 

April 2013
Lupin receives FDA approval for its Oral Contraceptive Pirmella™ 7/7/7 and Pirmella™ 1/35 Tablets
Date: April 26Size: 173Kb
Lupin announces favorable ruling for generic Yaz® Oral Contraceptive Tablets
Date: April 17Size: 172Kb
Lupin launches its Oral Contraceptive DayseeTM Tablets in the US Market Generic of Seasonique® Tablets
Date: April 12Size: 141Kb

 

March 2013
Lupin Launches Generic Diovan HCT® Tablets
Date: March 22Size: 145Kb

 

February 2013
Lupin Receives FDA Approval for New Drug Application for SUPRAX® Oral Suspension, 500 mg/5mL
Date: February 22Size: 145Kb
Lupin Receives FDA Approval for Lorazepam Oral Concentrate USP, 2 mg/mL
Date: February 21Size: 138Kb

 

January 2013
Record Sales and Profits - Quarter III Results, FY 2012?13
Date: January 31Size: 222Kb
Lupin Receives FDA Approval for Generic Plan B® Tablets, 0.75 mg® Tablets
Date: January 24Size: 169Kb
Lupin Receives FDA Approval to Market Generic Lutera® Tablets
Date: January 22Size: 169Kb